To the Right Patients...

Sep 21, 2010

Health insurance giant Aetna is funding a study of whether women who should be offered genetic screening tests for breast and ovarian cancer risk are indeed being offered the tests, reports the Wall Street Journal's Health Blog.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries
Genomic, Epidemiological Analysis Traces SARS-CoV-2 P.1 Lineage Emergence in Brazil
Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy
Benchling Raises $200M in Series E Funding Round
Twist Bioscience, Pure Biologics Partner on Antibody Discovery for Immunoncology
Bruker Reports Preliminary Q1 Revenues of $549M to $554M, Beating Analyst Expectations

The Scan

More to Mix and Match

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

National Academy of Sciences May Expel Members

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

Nucleic Acids Research Papers on DNA-Bound Proteins, Transcriptional Activation, More

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Menu